Biomet, Inc. Announces Fiscal Year 2015 First Quarter Conference Call

WARSAW, Ind.--()--Biomet, Inc. announced today that in conjunction with its Fiscal 2015 First Quarter release, you are invited to participate in the conference call on Thursday, October 9, 2014 at 9:00 a.m. Eastern.

Individuals wishing to participate in the conference call may dial (877) 606-1415. International callers should dial (760) 666-3758. The conference ID number is 13790426.

About Biomet

Biomet, Inc. and its subsidiaries design, manufacture and market surgical and non-surgical products used primarily by orthopedic surgeons and other musculoskeletal medical specialists. Biomet's product portfolio includes hip and knee reconstructive products; sports medicine, extremities and trauma products; spine, bone healing and microfixation products; dental reconstructive products; and cement, biologics and other products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.

Contacts

Biomet, Inc.
Carolyn Beatty, Investor Relations, 574-372-1571
Barbara Goslee, Director, Investor Relations, 574-372-1514
Pat Richardson, Vice President, Investor Relations, 574-372-3941

Contacts

Biomet, Inc.
Carolyn Beatty, Investor Relations, 574-372-1571
Barbara Goslee, Director, Investor Relations, 574-372-1514
Pat Richardson, Vice President, Investor Relations, 574-372-3941